Premium
The oral clearance and beta‐adrenoceptor antagonist activity of propranolol after single dose are not related to debrisoquine oxidation phenotype.
Author(s) -
Lennard MS,
Jackson PR,
Freestone S,
Ramsay LE,
Tucker GT,
Woods HF
Publication year - 1984
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1984.tb02441.x
Subject(s) - debrisoquine , propranolol , antagonist , citation , medicine , pharmacology , computer science , psychology , library science , cyp2d6 , receptor , metabolism , cytochrome p450